ClinicalTrials.gg
CompletedNCT05153876NLPH-OPENUpdated May 16, 2024

An Open Internet-based Survey and Natural Language Processing Project Analysing Written Monologues by Headache Patients

An observational study in Headache Disorders, Tension-Type Headache and Migraine Disorders, sponsored by University Hospital, Ghent. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-16.

Sponsored by University Hospital, Ghent · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
1,150
Ages
18 Years and older
Sex
All
01

Study summary

Headache disorders are among the most prevalent medical conditions worldwide. The diagnosis of headache disorders is based on medical history taking. Digital solutions such as natural language processing (NLP) may be of aid to understand the linguistic aspects of headache attack and headache related disability descriptions by patients. Participants will provide a written description of their headache disorder. The results will hopefully lead to a better understanding of the potential use of NLP in headache disorders.

02

Conditions studied

  • Headache Disorders
  • Tension-Type Headache
  • Migraine Disorders
  • Cluster Headache
  • TACS
  • Secondary Headache Disorder

Keywords

  • Migraine
  • Natural Language Processing
  • Headache
03

In context

Headache Disorders

145 studies on the registry are indexed under Headache Disorders; 37 are open to participants now.

This study's enrollment of 1,150 is above the median of 131 across 46 observational studies indexed under Headache Disorders.

Browse Headache Disorders studies →

Lead sponsor

University Hospital, Ghent is the lead sponsor of 689 studies on the registry; 160 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with headache disorders

Eligibility criteria

Inclusion Criteria:

  • 18 year or older
  • Have a headache disorder with at least one headache attack over the last three months
  • voluntary participation
  • accepted the patient information sheet and gave
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
1,150 participants (actual)
Patient registry
No

Groups and cohorts

  • Participants

    Participants filling in the questionnaires

    Other: Questionnaires

Interventions

  • OtherQuestionnaires

    Headache attack descriptions, Headache related disability descriptions, Questionnaires, MIDAS, MSQv2.1, SF36

06

What researchers measure

Primary outcomes

  1. Lexical diversity and differences between migraine and cluster headache

    Chi-square measurement of a word token used by migraine patients versus cluster headache patients

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. Accuracy of machine learning experiments for the correct classification of headache disorders

    Machine learning experiments to investigate the potential to build modelling algorithms that accurately classify the self-given diagnosis by the patient based on text.

    Time frame: through study completion, an average of 1 year

  2. F1 scores of machine learning experiments for the correct classification of headache disorders

    Machine learning experiments to investigate the potential to build modelling algorithms that accurately classify the self-given diagnosis by the patient based on text.

    Time frame: through study completion, an average of 1 year

  3. Word counts

    Counts of word tokens of different headache disorder groups

    Time frame: through study completion, an average of 1 year

  4. Sentences counts

    Counts of sentence tokens of different headache disorder groups

    Time frame: through study completion, an average of 1 year

  5. Paragraph counts

    Counts of paragraph tokens of different headache disorder groups

    Time frame: through study completion, an average of 1 year

  6. Term-frequency inverse document frequency scores (TF-IDF)

    TF-IDF scores of word tokens of different headache disorder groups

    Time frame: through study completion, an average of 1 year

  7. Migraine Disabillity Assessment [MIDAS] score calculation with text input

    Machine learning experiments to investigate the potential to build modelling algorithms that accurately predict the impact score from Migraine Disabillity Assessment \[MIDAS\] based on text.

    Time frame: through study completion, an average of 1 year

  8. Migraine Specific Questionaire versie 2.1 [MSQv2.1] score calculation with text input

    Machine learning experiments to investigate the potential to build modelling algorithms that accurately predict the impact score from Migraine Specific Questionaire versie 2.1 \[MSQv2.1\] based on text.

    Time frame: through study completion, an average of 1 year

  9. RAND SF-36 Dutch version score calculation with text input

    Machine learning experiments to investigate the potential to build modelling algorithms that accurately predict the impact score from RAND SF-36 Dutch version based on text.

    Time frame: through study completion, an average of 1 year

07

Study locations

1 site
  • University Hospital, Ghent: Department of Neurology
    Ghent, 9000, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05153876
Responsible party
Sponsor
First posted
Dec 10, 2021
Start date
Oct 11, 2021
Primary completion
Dec 31, 2023
Completion
Jan 1, 2024
Last update
May 16, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion